DM: Carbohydrates (2007)
The studies included in the meta-analysis met these criteria:
- published in English between 1981 and 2001
- randomized cross-over or parallel experimental design
- at least 12 days duration
- subjects had type 1 or type 2 diabetes
- HbA1c or fructosamine used as outcome measures of glycemic control
- modification of at least two meals per day
Recruitment: Studies were identified by Medline and internet searches using the key words "glycemic" and "diabetes."
Design: Meta-Analysis
Blinding used (if applicable): not applicable
Intervention (if applicable): not applicable
Statistical Analysis: The steps used to execute the meta-analysis were drawn from Petitti, using a fixed-effects model.
- The variance for each study was calculated under these assumptions:
- the two values for each person were independent
- the two values for each person were dependent with a correlation of 0.34
- The studies were weighted by the reciprocal of the variance. The overall effect estimate and 95% CIs were then computed using these weights.
- The hypothesis of homogeneity of effect was tested, and where it was rejected, a sensitivity analysis was conducted by removing individual studies one by one.
Timing of Measurements not applicable
Dependent Variables
- HbA1c
- fructosamine
Independent Variables
- the average GI of low-GI and high GI diets was 83 and 65 respectively, on the bread scale
- study duration ranged from 12 days to 12 months
Control Variables
- baseline values of HbA1c and fructosamine
- length of study
Initial N: 14 studies identified; number of subjects in each ranged from 6 to 104
Attrition (final N): not applicable
Age: not given
Ethnicity: not given
Other relevant demographics: 356 subjects had type 1 diabetes and 153 subjects had type 2 diabetes
Anthropometrics: not given
Location: not applicable
Mean difference and CI between low-GI and high-GI groups
Variables |
Difference in endpoints between low-GI and high-GI groups |
Difference in endpoints between low-GI and high-GI groups, controlling for baseline values |
HbA1c, assuming dependence; change inabsolute percentage points |
-0.40, -0.66 to -0.14 |
-0.33, -0.59 to -0.07 |
HbA1c, assuming independence; change inabsolute percentage points |
-0.43, -0.72 to-0.13 |
-0.34, -0.64 to -0.05 |
Fructosamine, assuming dependence; change in mmol/l |
-0.17, -0.30 to -0.04 |
-0.19, -0.32 to -0.06 |
Fructosamine, assuming independence; change in mmol/l |
-0.18, -0.33 to -0.02 | -0.2, -0.35 to -0.04 |
Combined HbA1c and fructosamine data, assuming dependence; [value for low-GI -value for high-GI) x 100/value for high-GI] |
-6.8 %, -8.1 to - 5.5 | -7.3%, -8.6 to -6.0 |
Combined HbA1c and fructosamine data, assuming dependence; value for low-GI -value for high-GI) x 100/value for high-GI] |
-6.8%, -8.2 to-5.4 | -7.4%, -8.8 to -6.0 |
Other Findings
Mean differences in outcomes between subjects with type 1 and type 2 diabetes, using combined analysis of HbA1c and fructosamine:
- assuming dependence: -10.6%,(-12.7 to -8.6)
- assuming independence: -6.1% (-7.8 to -4.3)
The meta-analysis provides objective evidence that targeting postprandial hyperclycemia via choice of low-GI foods has a small but clinically useful effect on medium-term glycemic control in diabetes.
University/Hospital: | University of Sydney, University of technology, Prince of Wales Hospital (all Australia) |
Quality Criteria Checklist: Review Articles
|
|||
Relevance Questions | |||
1. | Will the answer if true, have a direct bearing on the health of patients? | Yes | |
2. | Is the outcome or topic something that patients/clients/population groups would care about? | Yes | |
3. | Is the problem addressed in the review one that is relevant to dietetics practice? | Yes | |
4. | Will the information, if true, require a change in practice? | Yes | |
Validity Questions | |||
1. | Was the question for the review clearly focused and appropriate? | Yes | |
2. | Was the search strategy used to locate relevant studies comprehensive? Were the databases searched and the search termsused described? | Yes | |
3. | Were explicit methods used to select studies to include in the review? Were inclusion/exclusion criteria specified andappropriate? Wereselectionmethods unbiased? | Yes | |
4. | Was there an appraisal of the quality and validity of studies included in the review? Were appraisal methodsspecified,appropriate, andreproducible? | No | |
5. | Were specific treatments/interventions/exposures described? Were treatments similar enough to be combined? | Yes | |
6. | Was the outcome of interest clearly indicated? Were other potential harms and benefits considered? | Yes | |
7. | Were processes for data abstraction, synthesis, and analysis described? Were they applied consistently acrossstudies and groups? Was thereappropriate use of qualitative and/or quantitative synthesis? Was variation in findings among studies analyzed? Were heterogeneity issued considered? If data from studies were aggregated for meta-analysis, was the procedure described? | Yes | |
8. | Are the results clearly presented in narrative and/or quantitative terms? If summary statistics are used, are levels ofsignificance and/or confidence intervals included? | Yes | |
9. | Are conclusions supported by results with biases and limitations taken into consideration? Are limitations ofthe review identified anddiscussed? | Yes | |
10. | Was bias due to the review's funding or sponsorship unlikely? | No | |